- Joining strategic Danish-Swedish life science cluster
supports overall Eagle Genomics mission to accelerate the
generative economy through the digital reinvention of
science
CAMBRIDGE, England,
May 24, 2022 /PRNewswire/ -- Eagle
Genomics, the software business pioneering the application of
network science to biology, has announced that it has joined
Medicon Valley Alliance (MVA), a non-profit membership organization
in the Danish-Swedish life science cluster in Medicon Valley.
Located across the intersection of Danish and Swedish
innovation, MVA has a vibrant ecosystem, with an array of
high-impact businesses supported by world-class universities and
research institutions – features that help make it one of the
Nordics' strongest life science clusters.
Greater Copenhagen is a
recognized global center for microbiome research. Its Microbiome
Signature Project MVA is committed to providing investment as well
as international research facilities and activities, and to
nurturing the talent needed to support the fast growth of this
sector. Fermentation research, for example, is a core competence
for both organisations and universities in the MVA ecosystem. From
food production and food security, climate change, as well as the
effects of the microbiome in health and disease, MVA and its
members have a market-leading reputation.
Dr Christian Roghi, Director,
Microbiome Solutions, Eagle Genomics, said: "With our
focus on the bio-economy – the biological science-inspired circular
economy that is addressing challenges in areas such as food and
nutrition, health as well as the environment — it's been an
important strategic decision for Eagle Genomics to join MVA.
Ultimately, being part of this cluster is helping us to fulfill our
purpose: accelerating the growth of a new global 'generative
economy' through the digital reinvention of science."
Anthony Finbow, CEO, Eagle
Genomics, said: "We're pleased to be to join MVA, as we
continue to grow and engage in pivotal multi-national partnerships
and relationships. By supporting research and development in
critical areas like the microbiome with our AI-augmented knowledge
discovery platform e[datascientist]™, we are supporting
organizations to build a more generative, sustainable future for
our food, water, soil, and health. Working with this important
European science hub provides another exciting opportunity to meet
our goal of becoming the world's global life sciences knowledge
discovery hub."
Notes to Editor
About Eagle Genomics
Eagle Genomics is innovating at the intersection of biology, data
sciences and bioinformatics, accelerating the generative economy
through the digital reinvention of science. Its award-winning
AI-augmented knowledge discovery platform, e[datascientist]™,
empowers scientists to exploit multi-dimensional data in minutes
rather than months, to help companies conduct science-led
innovation for next-generation products. It supports the entire
innovation workflow - from hypothesis through insight to product
claims – helping bring novel, safer and sustainable products to
market, faster, across the Food and Nutrition, Beauty and Personal
Care, AgBio and BioPharma industries.
Eagle Genomics is forging strategic relationships with leading
scientific establishments focused on the microbiome and in the UK
has helped shape the Microbiome Strategic Roadmap. A Cambridge, UK-headquartered business with a
global presence, it has sites in London's Knowledge Quarter, Hyderabad, India, New York's Genome Center as well as
Paris' Station F, Potsdam Science
Park, Germany and Kyiv, Ukraine. Find out more at
www.eaglegenomics.com.
Contacts
Eagle Genomics
Dr Priya
Kalia, Global Communications
priya.kalia@eaglegenomics.com
Media Enquiries – Eagle Genomics
Carina Birt, Sarum PR
+44 7970 006624
carina@sarumpr.com
Logo:
https://mma.prnewswire.com/media/1681594/Eagle_Genomics_logo.jpg